Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioscan Research has developed "Cerebo," a portable, non-invasive diagnostic device for rapid detection of intracranial hemorrhage at the point of care. The solution leverages optics, electronics, mechanics, and machine learning to provide fast triage and monitoring in trauma settings. The company positions its product as an alternative to CT scans for initial screening by paramedics or semi-skilled staff[2][3]. No published clinical trial results are referenced.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioscan Research.